Read + Share
Basenach E, Forster A, Raab P, Alzein S, et al. Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type
2 carrying the NF2:c.784C>T p.(Arg262*) variant. Clin Neuropathol 2022;41:162-167.
PMID: 35445657
|
 |
|
Basenach E, Forster A, Raab P, Alzein S, et al. Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type
2 carrying the NF2:c.784C>T p.(Arg262*) variant. Clin Neuropathol 2022;41:162-167.
PMID: 35445657
|
|
|
|